Skip to search formSkip to main contentSkip to account menu

MK 4305

Known as: MK-4305, MK4305 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

suvorexant

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Update on emerging drugs for insomnia
In recent years, there has been no evidence that the problem of chronic insomnia has faded in the least in US adults; on the… 
2012
2012
The single dose pharmacokinetic (PK) and pharmacodynamic (PD) profiles of suvorexant (MK-4305); a dual orexin receptor antagonist, in healthy male subjects
2012
2012
Synthetic method for anti-sleeplessness medicine MK-4305 intermediate
The invention belongs to the field of organic synthesis and in particular relates to a synthesis method for an anti-sleeplessness… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)